Drug
EC905 clinical trials
Also written EC905.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses EC905 is read from its arms, and is right about nine times in ten.
Testing it · 5
- EC905 Pharmacokinetic Profile StudyCompletedPhase 1Astellas Pharma Europe B.V.NCT02634489Written as EC905
- A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination TabletCompletedPhase 1Astellas Pharma Europe B.V.NCT01943487Written as EC905
- A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)CompletedPhase 1Astellas Pharma Europe B.V.NCT01953848Written as EC905
- A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and TamsulosinCompletedPhase 1Astellas Pharma Europe B.V.NCT01953887Written as EC905
- A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination TabletCompletedPhase 1Astellas Pharma Europe B.V.NCT01953861Written as EC905